This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor.—Sodium fluoride is now being given to patients for the treatment of vertigo, for sensorineural hearing losses, and for tinnitus. In other words, it is being suggested as a logical and rational treatment for those patients with the classic symptoms of Ménière's disease. All of this, of course, is based on the theoretical possibility that otospongiosis, with its histopathological and biochemical changes, is capable of affecting the inner ear and can be demonstrated by current roentgenographic means. This is an illogical and perhaps dangerous trend in thought.
It has only been several decades since otologists, on encountering a patient with no obvious ear disease and a substantial conductive hearing loss, made the diagnosis of "clinical otosclerosis." This was because the disease could not be proved by histopathological examination of excised tissue. It was only after fixation of the footplate had been demonstrated unequivocally at surgery in the
CHANDLER JR. Sodium Fluoride for Méniére's Disease? Arch Otolaryngol. 1980;106(7):445. doi:10.1001/archotol.1980.00790310069021
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: